2020
DOI: 10.1016/j.jinf.2020.10.016
|View full text |Cite
|
Sign up to set email alerts
|

Developing new therapeutic approaches for treating infections caused by multi-drug resistant Acinetobacter baumannii

Abstract: Antimicrobial resistance (AMR) represents a major challenge to global health. This problem is most apparent in healthcare facilities, with a comparatively small number of pathogens being responsible for a substantial burden of hospital acquired infections globally. One of the key pathogens is the Gram-negative coccobacilli, Acinetobacter baumannii. It has been estimated that between 47% and 93% of A. baumannii infections are associated with multi-drug resistance (MDR), which is facilitated through a variety of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
18
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 34 publications
(19 citation statements)
references
References 52 publications
(56 reference statements)
1
18
0
Order By: Relevance
“…A. baumannii and S. aureus are some of the more common opportunistic pathogens which cause community and nosocomial infections. Unfortunately, the number of multidrug-resistant A. baumannii isolates has increased significantly [ 18 , 19 ]. Resistance to antibiotics is widespread in S. aureus , which methicillin-resistant S. aureus (MRSA) are the most important clinically [ 20 ].…”
Section: Introductionmentioning
confidence: 99%
“…A. baumannii and S. aureus are some of the more common opportunistic pathogens which cause community and nosocomial infections. Unfortunately, the number of multidrug-resistant A. baumannii isolates has increased significantly [ 18 , 19 ]. Resistance to antibiotics is widespread in S. aureus , which methicillin-resistant S. aureus (MRSA) are the most important clinically [ 20 ].…”
Section: Introductionmentioning
confidence: 99%
“…Extensive and pan antibiotic-resistant A. baumannii infections are not only associated with poorer patient outcomes with significant morbidity and mortality but are also difficult to eradicate from clinical environments despite infection control procedures 2 . The success of the species as a serious global pathogen can be attributed to a highly plastic genome with significant mutation rates and frequent acquisition of genes that confer extensive antimicrobial resistance, increase virulence in the host, and/or enhance survival in unfavorable conditions over long periods 3 , 4 . These characteristics have favored the expansion of multi-drug resistant clonal lineages, including the two globally disseminated clones, global clone 1 (GC1) and global clone 2 (GC2), emphasizing a need to better understand mechanisms for virulence and survival in host and nosocomial contexts.…”
Section: Introductionmentioning
confidence: 99%
“…Multidrug-or even pandrug-resistant Ac. baumannii are emerging pathogens associated with a range of infections and there is a pressing need to nd new therapeutics [42,43]. It should therefore be further explored whether saposin-like bacteriocins could be used alone or in combination with other antimicrobials to ght Ac.…”
Section: Discussionmentioning
confidence: 99%